tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:SCLP Stock Latest News

Scancell Holdings Charts Risky but Promising Phase III Path
Company AnnouncementsScancell Holdings Charts Risky but Promising Phase III Path
24d ago
Scancell Secures FDA Green Light for Phase 3 Melanoma Trial as Pipeline and Cash Runway Advance
PremiumCompany Announcements
Scancell Secures FDA Green Light for Phase 3 Melanoma Trial as Pipeline and Cash Runway Advance
26d ago
Scancell Wins FDA Nod for Phase 3 Melanoma Trial of iSCIB1+ After Strong Phase 2 Data
PremiumCompany Announcements
Scancell Wins FDA Nod for Phase 3 Melanoma Trial of iSCIB1+ After Strong Phase 2 Data
29d ago
Scancell Sets Date for Interim Results as Cancer Immunotherapy Portfolio Advances
PremiumCompany Announcements
Scancell Sets Date for Interim Results as Cancer Immunotherapy Portfolio Advances
1M ago
Scancell’s iSCIB1+ Shows Promising Results in Melanoma Trial
PremiumCompany Announcements
Scancell’s iSCIB1+ Shows Promising Results in Melanoma Trial
3M ago
Scancell’s iSCIB1+ Shows Promising Results in Melanoma Treatment
PremiumCompany AnnouncementsScancell’s iSCIB1+ Shows Promising Results in Melanoma Treatment
4M ago
Scancell Holdings Successfully Passes AGM Resolutions
Premium
Company Announcements
Scancell Holdings Successfully Passes AGM Resolutions
4M ago
Scancell’s Modi-1 Moditope Study: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
Scancell’s Modi-1 Moditope Study: A Potential Game-Changer in Cancer Treatment
4M ago
SCLP
SCOPE Study: Scancell’s Promising Melanoma Vaccine Trials
PremiumCompany Announcements
SCOPE Study: Scancell’s Promising Melanoma Vaccine Trials
4M ago
SCLP
Scancell Holdings Announces AGM and Annual Report Release
PremiumCompany Announcements
Scancell Holdings Announces AGM and Annual Report Release
5M ago
Scancell Holdings: Strategic Share Acquisition by Vulpes Testudo Fund
PremiumCompany Announcements
Scancell Holdings: Strategic Share Acquisition by Vulpes Testudo Fund
5M ago
Scancell Holdings’ Earnings Call: Strategic Growth Amid Financial Challenges
PremiumCompany Announcements
Scancell Holdings’ Earnings Call: Strategic Growth Amid Financial Challenges
5M ago
Scancell Holdings Reports Positive Trial Results and Strategic Developments
PremiumCompany AnnouncementsScancell Holdings Reports Positive Trial Results and Strategic Developments
6M ago
Scancell Holdings to Announce Year-End Results and Business Update
Premium
Company Announcements
Scancell Holdings to Announce Year-End Results and Business Update
6M ago
Scancell Holdings Sees Increased Stake by Vulpes Testudo Fund
Premium
Company Announcements
Scancell Holdings Sees Increased Stake by Vulpes Testudo Fund
7M ago
Scancell Holdings Sees Significant Share Acquisition by Vulpes Testudo Fund
PremiumCompany Announcements
Scancell Holdings Sees Significant Share Acquisition by Vulpes Testudo Fund
7M ago
Scancell’s iSCIB1+ Shows Promising Results in Late-Stage Melanoma Trial
PremiumCompany Announcements
Scancell’s iSCIB1+ Shows Promising Results in Late-Stage Melanoma Trial
7M ago
Scancell Holdings Announces Share Option Exercise and Increased Voting Shares
PremiumCompany Announcements
Scancell Holdings Announces Share Option Exercise and Increased Voting Shares
7M ago
Scancell Advances iSCIB1+ Immunotherapy in Phase 2 Melanoma Study
PremiumCompany Announcements
Scancell Advances iSCIB1+ Immunotherapy in Phase 2 Melanoma Study
8M ago
Scancell Holdings Sees Increased Investment from Vulpes Testudo Fund
PremiumCompany AnnouncementsScancell Holdings Sees Increased Investment from Vulpes Testudo Fund
9M ago
Scancell Partners with NHS to Fast-Track Melanoma Vaccine Access
Premium
Company Announcements
Scancell Partners with NHS to Fast-Track Melanoma Vaccine Access
11M ago
Scancell to Present Promising Phase 2 Melanoma Vaccine Data at AACR 2025
Premium
Company Announcements
Scancell to Present Promising Phase 2 Melanoma Vaccine Data at AACR 2025
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >